Stericile ltd successfully raised £150,000

This site uses cookies. By using this site you agree to receiving cookies. View Policy.

152%

Raised: £229,200

Investors: 276

Target: £150,000

Equity: 11.58%

Pre-money valuation: £1,750,000

Stericile Ltd is a chemical R&D company who have scientifically created a disinfectant which can help combat the epidemic of Hospital Acquired Infections. Its products are designed for the healthcare market and they have secured a UK national supplier who currently supplies over 15,000 customers.

Over £400,000 spent on creating one unique chemical solution
Passed all NHS Fraise tests for Clostridium Difficile (C.Diff)
More than 4 years in development
Passed all independent tests carried out by Blutest Laboratories Ltd

Idea

Stericile Promo Video

We believe that we have achieved one of the biggest technological advancement in the peracetic acid market in 50 years. Our solution has been designed to be safe to touch but without lowering its killing ability, it's also an effective surface cleaner and has a pleasant lemon scent.

We are seeking investment to grow our production capacity for our proven and tested disinfectants designed for the UK healthcare and global disinfectant markets. It is currently estimated in the UK alone that over 300,000 people suffer from a Hospital Acquired Infection which lead to almost 9,000 premature deaths.

Our unique scientific formulation has created a "one product does all" universal disinfectant Spray, Floor Cleaner and Surface Wipe which replaces the need for multiple cleaning products, as our solution kills all known hospital viruses & bacteria.

We have secured a UK national supplier who currently supply over 15,000 healthcare customers with less effective products. These customers include care-homes, medical centres, dentist & doctor surgeries and more.

We believe our products are needed within the healthcare market, not only because they simplify the sanitation process for the nurses and cleaners but also due to its competitive price which would create massive savings when compared to market leaders currently being used.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

To see the rest of the Stericile ltd pitch, join now. It's free, quick and easy.

Due to financial regulations, you need to join our community to view the full investment opportunity.

Join

Already registered?
Log in

Investments of this nature carry risks to your capital, including illiquidity, lack of dividends and dilution. Balance risk with a diversified portfolio. Read more. Approved as a financial promotion by Crowdcube Capital Limited, which is authorised and regulated by the Financial Conduct Authority.

Investment opportunities are not offers to the public and investors must be eligible Crowdcube members. Further restrictions and Crowdcube's limitation of liability are set out in the Investor Terms and Conditions. Please seek independent advice as required as Crowdcube does not give investment or tax advice.

Stericile ltd has been given advance assurance by HMRC that the proposed share issue is likely to qualify for Enterprise Investment Scheme (EIS) tax relief.

Tax relief is available to individuals only, with income tax relief currently set at 30 per cent of the cost of the shares for the tax year in which the investment was made. The tax reliefs can also reduce your Capital Gains Tax bill. Read More.

Availability of tax relief depends on your individual and the company’s ongoing circumstances and applicable law.

Idea

To see the rest of the Stericile ltd pitch, join now. It's free, quick and easy.

Risk warning

Investing

Raising

About us

Legal